| Biological Sciences | Lifetime | 9 | US 7 | 100.00 |
| Medical and Health Sciences | Lifetime | 271 | US 145 | 99.99 |
| Biological Sciences | 2021-2025 | 30 | US 2 | 99.97 |
| Genetics | Lifetime | 1 | US 1 | 100.00 |
| Epidemiology | Lifetime | 16 | US 10 | 99.97 |
| Surgery | Lifetime | 203 | US 116 | 99.82 |
| Public, Environmental and Occupational Health | Lifetime | 692 | US 354 | 99.03 |
| Immunology | Lifetime | 431 | US 227 | 98.87 |
| Gastroenterology | Lifetime | 92 | US 41 | 98.76 |
| Hepatology | Lifetime | 442 | US 146 | 96.11 |
| Hematology | Lifetime | 734 | US 364 | 93.47 |
| Medical Genetics | Lifetime | 724 | US 360 | 91.78 |
| Genetics | 2021-2025 | 4 | US 1 | 99.97 |
| Epidemiology | 2021-2025 | 231 | US 78 | 98.28 |
| Surgery | 2021-2025 | 815 | US 311 | 92.82 |
| Immunology | 2021-2025 | 384 | US 141 | 89.44 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 1 | US 1 | 99.98 |
| Inflammatory Bowel Disease | Lifetime | 1 | US 1 | 100.00 |
| Microscopic Colitis | Lifetime | 1 | US 1 | 100.00 |
| Autoimmune and Inflammatory Disorders | Lifetime | 1 | US 1 | 100.00 |
| Eosinophilic Esophagitis | Lifetime | 3 | US 3 | 99.96 |
| Pregnancy and Medication Impact | Lifetime | 2 | US 2 | 99.87 |
| Diverticular Disease and Complications | Lifetime | 4 | US 3 | 99.90 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 10 | US 3 | 99.84 |
| Celiac Disease Research and Management | Lifetime | 5 | US 3 | 99.71 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 18 | US 5 | 99.85 |
| Diagnosis and treatment of tuberculosis | Lifetime | 9 | US 2 | 99.78 |
| Liver Diseases and Immunity | Lifetime | 13 | US 10 | 99.79 |
| Biosimilars and Bioanalytical Methods | Lifetime | 10 | US 2 | 99.61 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 142 | US 79 | 99.54 |
| Acute Lymphoblastic Leukemia research | Lifetime | 127 | US 85 | 99.39 |
| Pharmacological Effects of Natural Compounds | Lifetime | 164 | US 24 | 98.61 |
| Gastrointestinal motility and disorders | Lifetime | 106 | US 41 | 98.90 |
| Gastrointestinal disorders and treatments | Lifetime | 287 | US 126 | 98.73 |
| Mycobacterium research and diagnosis | Lifetime | 302 | US 113 | 98.34 |
| Systemic Lupus Erythematosus Research | Lifetime | 382 | US 145 | 98.78 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 776 | US 355 | 98.26 |
| Pharmaceutical studies and practices | Lifetime | 282 | US 137 | 97.64 |
| Appendicitis Diagnosis and Management | Lifetime | 311 | US 125 | 97.23 |
| Pancreatitis Pathology and Treatment | Lifetime | 877 | US 323 | 96.69 |
| Anorectal Disease Treatments and Outcomes | Lifetime | 391 | US 147 | 96.53 |
| Colorectal Cancer Screening and Detection | Lifetime | 966 | US 424 | 96.84 |
| IL-33, ST2, and ILC Pathways | Lifetime | 422 | US 179 | 96.13 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 102 | US 33 | 94.32 |
| Gastrointestinal Bleeding Diagnosis and Treatment | Lifetime | 454 | US 128 | 93.67 |
| Whipple's Disease and Interleukins | Lifetime | 68 | US 20 | 92.93 |
| Andrographolide Research and Applications | Lifetime | 157 | US 11 | 80.65 |
| Inflammatory Bowel Disease | 2021-2025 | 4 | US 1 | 99.95 |
| Microscopic Colitis | 2021-2025 | 10 | US 4 | 99.86 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 19 | US 6 | 99.30 |
| Eosinophilic Esophagitis | 2021-2025 | 35 | US 18 | 99.04 |
| Helicobacter pylori-related gastroenterology studies | 2021-2025 | 47 | US 11 | 98.01 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 149 | US 76 | 98.13 |
| Autoimmune and Inflammatory Disorders | 2021-2025 | 24 | US 6 | 97.71 |
| Liver Diseases and Immunity | 2021-2025 | 127 | US 33 | 95.24 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 170 | US 69 | 91.21 |
| Diagnosis and treatment of tuberculosis | 2021-2025 | 120 | US 23 | 89.51 |
| Pregnancy and Medication Impact | 2021-2025 | 270 | US 91 | 88.27 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 505 | US 101 | 89.68 |
| Celiac Disease Research and Management | 2021-2025 | 355 | US 53 | 80.41 |
